跳至主要内容
临床试验/ACTRN12618001622291
ACTRN12618001622291已完成2 期

A randomised controlled trial of buffered salt solution versus 0.9% sodium chloride as fluid therapy for patients with diabetic ketoacidosis.

Trial Management Committee0 个研究点目标入组 93 人开始时间: 2018年10月2日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
93

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
16 Years 至 o limit(—)
性别
All

入选标准

  • Patients greater than or equal to 16 years of age, admitted to the emergency department at participating sites with a diagnosis of diabetic ketoacidosis, which was defined as:
  • Blood glucose level greater than 14 mmol/L
  • pH less than 7.25 OR serum bicarbonate less than 15 mmol/L
  • ICU admission required in the judgement of the treating clinician

排除标准

  • Age less than 16
  • Serum potassium greater than 6.5 mmol/L prior to randomisation
  • Patients with hyperosmotic hyperglycaemic, non-ketotic syndrome
  • Patients who have previously been included in this trial

研究者

发起方
Trial Management Committee

相似试验

Sodium Chloride Or Plasmalyte Evaluation for... | 临床试验